Technical Specifications
| Drug Composition | Ibrutinib 140 mg Capsules |
|---|---|
| Variant / Strength | 140 mg |
| Dosage Form / Type | Capsules |
| Product Benefits | Mantle-cell lymphoma & Blood cancer (Chronic lymphocytic leukemia) |
| Packaging Type | Bottle |
| Delivery Time | 7 - 15 Days, as per delivery location. |
| Country of Origin | Made in India |
| Export Destinations | USA, UK, UAE, Philippines, Thailand, Kenya, Nigeria, Germany, Canada, Mexico, and 65+ more countries |
| Export Route | Shipped via temperature-controlled international air courier with full customs documentation |
Product Overview & Description
Ibrutinib Capsule is prescribed for mantle-cell lymphoma and chronic lymphocytic leukemia, including cases that have undergone at least one prior therapy. The duration of treatment depends on your response, with the doctor conducting regular blood tests to monitor blood cell counts, as the medication can decrease cell numbers, potentially heightening susceptibility to infections. Common side effects include headache, diarrhea, and nausea.
Submit Quotation Request
Verified Customer Reviews (0)
Frequently Asked Questions
ℹ️ Information reviewed by Medibliss Lifesciences Editorial Team. Last reviewed: August 2026. Data sourced from manufacturer documentation and WHO-GMP certificates.
Disclaimer: The information provided on this page is for informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Medibliss Lifesciences acts solely as an exporter and supplier. Please consult your physician or a qualified healthcare provider before starting any medication. We do not manufacture these products and rely on the manufacturer's provided documentation and WHO-GMP certifications for product information.